Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EUDA Health Holdings (EUDA) Minority Interest (2021 - 2025)

EUDA Health Holdings (EUDA) has disclosed Minority Interest for 4 consecutive years, with -$19009.0 as the latest value for Q4 2024.

  • Quarterly Minority Interest fell 214.41% to -$19009.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$19009.0 through Dec 2024, down 214.41% year-over-year, with the annual reading at -$19009.0 for FY2024, 214.41% down from the prior year.
  • Minority Interest for Q4 2024 was -$19009.0 at EUDA Health Holdings, down from $16615.0 in the prior quarter.
  • The five-year high for Minority Interest was $78818.0 in Q4 2021, with the low at -$19009.0 in Q4 2024.
  • Average Minority Interest over 4 years is $20982.0, with a median of $15008.0 recorded in 2023.
  • The sharpest move saw Minority Interest increased 23.27% in 2023, then plummeted 214.41% in 2024.
  • Over 4 years, Minority Interest stood at $78818.0 in 2021, then crashed by 82.9% to $13478.0 in 2022, then rose by 23.27% to $16615.0 in 2023, then tumbled by 214.41% to -$19009.0 in 2024.
  • According to Business Quant data, Minority Interest over the past three periods came in at -$19009.0, $16615.0, and $15008.0 for Q4 2024, Q4 2023, and Q1 2023 respectively.